AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Myomo has reiterated its 2025 revenue target of $40-$42 million, driven by growth in the O&P channel and MyoConnect. The company reported Q3 2025 revenue of $10.1 million, with record international revenues and a growing number of users. Management attributes the strong performance to the success of its MyoConnect platform, which enables users to control their prosthetic limbs with greater precision.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet